Murine models of Chlamydia pneumoniae infection and atherosclerosis

Journal of Infectious Diseases

Volumn 175, Issue 4, 1997, Pages 883-890

  Moazed, Teresa C ^a   Kuo, Cho Chou ^a   Grayston, J Thomas ^a   Campbell, Lee Ann ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROMA; BACTERIUM DETECTION; BACTERIUM ISOLATION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; DISEASE ASSOCIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0030940034     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/513986     Document Type: Article

References (32)

1. Wang SP, Grayston JT. Population prevalence antibody to Chlamydia pneumoniae, strain TWAR. In: Bowie WR, Caldwell HD, Jones R, et al., eds. Chlamydial infections. Cambridge, UK: Cambridge University Press, 1990;402-5.
2. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995;8:451-61.
3. Saikku P, Mattila K, Nieminen MS, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-5.
4. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116:273-8.
5. Linnamaki E, Leinonen M, Mattila K, Niemainen MS, Valtonen V, Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993; 87: 1130-4.
6. Thorn DH, Wang SP, Grayston JT, et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991; 11:547-51.
7. Thorn DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992; 268:68-72.
8. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992;82:158-61.
9. Kuo CC, Shor A, Campbell LA, Fukshi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167:841-9.
10. Campbell LA, O'Brien ER, Cappuccio AL, et al., Detection of Chlamydia pneumoniae (TWAR) in human coronary atherectomy tissues. J Infect Dis 1995; 172:585-8.
11. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young (15 to 35 year) adults. Proc Natl Acad Sci USA 1995;92:6911-4.
12. Grayston JT, Kuo CC, Coulson AS, et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995;92:3397-400.
13. Ong G, Thomas BJ, Mansfield OA, Davidson BR, Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996;49: 102-6.
14. Kuo CC, Gown AM, Benditt EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 1993; 13:1501-4.
15. Plump AS, Smith JD, Hayek T, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992;71:343-53.
16. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 1992; 89: 4471-5.
17. Reddick RL, Zhang SH, Maeda N. Atherosclerosis in mice lacking apo E: evaluation of lesional development and progression. Atheroscler Thromb 1994;14:141-7.
18. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994; 14:133-40.
19. Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Arterioscler Thromb 1994; 14:605-16.
20. Grayston JT, Kuo CC, Campbell LA, Wang SP. Chlamydia pneumoniae sp. nov. for Chlamydia sp. strain TWAR. Int J Syst Bacteriol 1989;39: 88-90.
21. Kuo CC, Grayston JT. A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 162:755-8.
22. Campbell LA, Kuo CC, Grayston JT. Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization. J Clin Microbiol 1987; 25: 1911-6.
23. Preparation of genomic DNA from bacteria. In: Ausubel FM, Brent R, Kingston RE, et al., eds. Current protocols, molecular biology. Vol 1. New York: Wiley Interscience, 1991; 9:unit 2.4.1.
24. Kuo CC, Chen HH, Wang SP, Grayston JT. Identification of a new group of Chlamydia psittaci strains called TWAR. J Clin Microbiol 1986;24: 1034-7.
25. Wang SP, Grayston JT. Microimmunofluorescence serological studies with the TWAR organism. In: Oriel D, Ridgway G, Schachter J, Taylor-Robinson D, Ward M, eds. Chlamydial infections. Cambridge, UK: Cambridge University Press, 1986:329-32.
26. Campbell LA, Melgosa MP, Hamilton J, Kuo CC, Grayston JT. Detection of Chlamydia pneumonia? by polymerase chain reaction. J Clin Microbiol 1992; 30:4334-9.
27. Sambrook J, Fritsch EF, Maniatis T. Analysis of genomic DNA by southern hybridization. In: Molecular cloning. A laboratory manual. 2nd ed. Vol 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989:9.31.
28. Ellison J, Dean M. Goldman D. Efficacy of fluorescence-based PCR-SSCP for detection of point mutations. Biotechniques 1993;4:684-91.
29. Yang ZP, Kuo CC, Grayston JT. A mouse model of Chlamydia pneumoniae, strain TWAR, pneumonitis. Infect Immum 1993;61:2037-40.
30. Yang ZP, Kuo CC, Grayston JT. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice. J Infect Dis 1995; 171:736-8.
31. Grönhagen-Risk C, Saikku P, Riska H, Froseth B, Grayston JT. Antibodies to TWAR-a novel type of Chlamydia-in sarcoidosis. In: Grassi C, Rizzato G, Pozzi E, eds. Sarcoidosis and other granulomatous disorders. Amsterdam: Excerpta Medica, 1988:297-301.
32. Black CM, Bullard JC, Staton GW Jr, Hutwagner LC, Perez RL. Seroprevalence of Chlamydia pneumoniae antibodies in patients with pulmonary sarcoidosis in north central Georgia. In: Mårdh PA, La Placa M, Ward ME, eds. Proceedings of the European Society for Chlamydial Research. Stockholm: Almquist & Wiksell International, 1992:175.